Anzeige
Meldung des Tages: Gold über 4.862 USD – auf dem Weg zu 5.000 USD: Warum A2 Gold jetzt in eine neue Liga aufsteigt

Corcept Therapeutics Aktie News

Aktie
WKN:  529882 ISIN:  US2183521028 US-Symbol:  CORT Branche:  Biotechnologie Land:  USA
37,08 $
+1,79 $
+5,07%
31,694 € 19:35:33 Uhr
Depot/Watchlist
Marktkapitalisierung *
7,36 Mrd. €
Streubesitz
12,97%
KGV
82,35
Index-Zuordnung
-

Corcept Therapeutics News

15.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PR Newswire
15.01.26 - PR Newswire
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm PR Newswire
14.01.26 - PR Newswire
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman PR Newswire
08.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PR Newswire
06.01.26 - PR Newswire
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman PR Newswire
17.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PR Newswire
11.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PR Newswire
03.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PR Newswire
13.02.25 - Börse-Global
Corcept Therapeutics Aktie: So macht Wirtschaft Spaß!
Die Aktie des Pharmaunternehmens Corcept Therapeutics erreichte einen historischen Höchststand von 71,3 US-Dollar und katapultierte damit die Marktkapitalisierung des ...
24.01.25 - PR Newswire
Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm PR Newswire
26.08.24 - PR Newswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT) PR Newswire
02.01.24 - PR Newswire
Thinking about trading options or stock in Exxon Mobil, Amazon.com, Meta Platforms, Enterprise Products Partners, or Corcept Therapeutics?
Thinking about trading options or stock in Exxon Mobil, Amazon.com, Meta Platforms, Enterprise Products Partners, or Corcept Therapeutics? PR Newswire
30.12.22 - PR Newswire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Corcept Therapeutics Incorporated Investors to Inquire About Class Action Investigation - CORT
NATIONALLY RANKED ROSEN LAW FIRM Encourages Corcept Therapeutics Incorporated Investors to Inquire About Class Action Investigation - CORT PR Newswire
27.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
17.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
06.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
13.12.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
29.09.20 - PR Newswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Corcept Therapeutics Incorporated (CORT) and Encourages Long-Term CORT Stockholders to Contact the Firm
SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Corcept Therapeutics Incorporated (CORT) and Encourages Long-Term CORT Stockholders to ...
11.04.19 - PR Newswire
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To ...
21.03.19 - PR Newswire
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated -- CORT
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated -- CORT PR Newswire

Newssuche

Videos

newspaper
20.01.26 +3,87%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »